Lobbying Filing Details
Total Spending
$50,000
Activities
1
Lobbyists
2
Gov't Entities
2
Filing Information
- Filing UUID:
ad1670db-1d2f-4bc8-98b2-80c74495c96f- Type:
- Q2 - 2nd Quarter - Report
- Period:
- 2014 - 2nd Quarter (Apr 1 - June 30)
- Date Posted:
- July 18, 2014 at 2:47 PM
- Income:
- $50,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Jeremy Rabinovitz Senior Executive Vice President Government Relations
Registrant
ML STRATEGIES, LLC
Government relations consulting firm
Washington, District of ColumbiaClient
ASTELLAS PHARMA US, INC.
Illinois, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesH.R. 4187, Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms (DISARM) Act of 2014; H.R. 4857, Ensuring Equal Access to Treatments Act of 2014
Foreign Entity Issues: Astellas Pharma, Inc. based in Tokyo, Japan and as identified in our Lobbying Registration has an interest as a pharmaceutical company in all of the isues with respect to which Astellas Pharma US has lobbied and listed above.
Lobbyists (2)
- JEREMY RABINOVITZ
- ABBY MATOUSEK
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES